Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Blog
Blog
Share
Blog
Dec 3, 2021
| Craig Burton
The Evidence Is Clear: Biosimilar Competition Will Achieve More Savings for Patients Than Build Back Better’s Negotiations
Blog
Dec 2, 2021
| Monét Stanford
How Inflation Penalties for Generic Medicines Could Worsen Drug Shortages
Blog
Nov 30, 2021
| Erica Klinger
2021 Report
Blog
Nov 29, 2021
| Erica Klinger
Process & Progress: A Recap of GRx+Biosims 2021
Blog
Nov 20, 2021
| Dan Leonard
AAM All Access Podcast: Lachman Consultants’ Robert Pollock
Blog
Nov 15, 2021
| Craig Burton
Inflation Rebate Proposal Builds on Bad Policy for Generics
Blog
Nov 12, 2021
| Monét Stanford
Medicare Negotiations Serve as a Catalyst to a Perpetual Monopoly
Blog
Nov 2, 2021
| Jonathan Kimball
Second Edition of AAM’s Blueprint to Enhance the Security of the U.S. Pharmaceutical Supply Chain
Blog
Oct 27, 2021
| Dan Leonard
AAM All Access Podcast: Celebrating Pharmacists
Blog
Oct 26, 2021
| Erik Komendant
Inflation-Based Rebates Need Not Apply
Blog
Oct 18, 2021
| Dan Leonard
AAM All Access Podcast: Lupin’s Vinita Gupta
Blog
Oct 18, 2021
| Rachel Schwartz
Five Breast Cancer Facts
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action